The Paired Siglecs in Brain Tumours Therapy: The Immunomodulatory Effect of Dexamethasone and Temozolomide in Human Glioma In Vitro Model.

Abstract

The paired sialic acid-binding immunoglobulin like lectins (Siglecs) are characterized by similar cellular distribution and ligand recognition but opposing signalling functions attributed to different intracellular sequences. Since sialic acid-Siglec axis are known to control immune homeostasis, the imbalance between activatory and inhibitory mechanisms of glycan-dependent immune control is considered to promote pathology. The role of sialylation in cancer is described, however, its importance in immune regulation in gliomas is not fully understood. The experimental and clinical observation suggest that dexamethasone (Dex) and temozolomide (TMZ), used in the glioma management, alter the immunity within the tumour microenvironment. Using glioma-microglia/monocytes transwell co-cultures, we investigated modulatory action of Dex/TMZ on paired Siglecs. Based on real-time PCR and flow cytometry, we found changes in SIGLEC genes and their products. These effects were accompanied by altered cytokine profile and immune cells phenotype switching measured by arginases expression. Additionally, the exposure to Dex or TMZ increased the binding of inhibitory Siglec-5 and Siglec-11 fusion proteins to glioma cells. Our study suggests that the therapy-induced modulation of the interplay between sialoglycans and paired Siglecs, dependently on patient's phenotype, is of particular signification in the immune surveillance in the glioma management and may be useful in glioma patient's therapy plan verification.

• Authors: Przemyslaw Wielgat, Natalia Wawrusiewicz-Kurylonek, Robert Czarnomysy, Karol Rogowski, Krzysztof Bielawski, Halina Car
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 4 (Feb 11 2021) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 33670244 (Publication Type: Journal Article)

Chemical References

• Antigens, CD
• Antigens, Differentiation, Myelomonocytic
• Immunologic Factors
• Lectins
• Membrane Proteins
• SIGLEC11 protein, human
• SIGLEC5 protein, human
• Dexamethasone
• Temozolomide

Topics

• Antigens, CD (pharmacology)
• Antigens, Differentiation, Myelomonocytic (pharmacology)
• Antineoplastic Combined Chemotherapy Protocols (pharmacology)
• Brain Neoplasms (drug therapy, immunology, pathology)
• Dexamethasone (pharmacology)
• Glioma (drug therapy, immunology, pathology)
• Humans
• Immunologic Factors (pharmacology)
• Lectins (pharmacology)
• Membrane Proteins (pharmacology)
• THP-1 Cells
• Temozolomide (pharmacology)